Avanos Medical Stock Today

AVNS Stock  USD 19.14  0.02  0.10%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 25

 
High
 
Low
Low
Avanos Medical is selling for under 19.14 as of the 28th of November 2024; that is 0.1 percent decrease since the beginning of the trading day. The stock's lowest day price was 19.14. Avanos Medical has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Avanos Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
21st of October 2014
Category
Healthcare
Classification
Health Care
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. The company has 45.96 M outstanding shares of which 552.33 K shares are presently shorted by private and institutional investors with about 2.14 trading days to cover. More on Avanos Medical

Moving together with Avanos Stock

  0.73CI Cigna CorpPairCorr

Moving against Avanos Stock

  0.87WGS GeneDx Holdings CorpPairCorr
  0.86LNSR LENSAR IncPairCorr
  0.82VREX Varex Imaging CorpPairCorr
  0.74XAIR Beyond AirPairCorr
  0.7CAH Cardinal HealthPairCorr
  0.63LH LaboratoryPairCorr

Avanos Stock Highlights

ESG Sustainability
Environmental
Governance
Social
Senior CEOMichael CPA
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.580.3978
Way Up
Slightly volatile
Gross Profit Margin0.370.5639
Way Down
Slightly volatile
Non Current Liabilities Total288.4 M221.5 M
Significantly Up
Very volatile
Debt Levels
Avanos Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Avanos Medical's financial leverage. It provides some insight into what part of Avanos Medical's total assets is financed by creditors.
Liquidity
Avanos Medical currently holds 209.1 M in liabilities with Debt to Equity (D/E) ratio of 0.24, which may suggest the company is not taking enough advantage from borrowing. Avanos Medical has a current ratio of 2.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Avanos Medical's use of debt, we should always consider it together with its cash and equity.

Other Non Cash Items

27.88 Million
Avanos Medical (AVNS) is traded on New York Stock Exchange in USA. It is located in 5405 Windward Parkway, Alpharetta, GA, United States, 30004 and employs 3,771 people. Avanos Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 880.54 M. Avanos Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 45.96 M outstanding shares of which 552.33 K shares are presently shorted by private and institutional investors with about 2.14 trading days to cover. Avanos Medical currently holds about 106.5 M in cash with 32.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.26.
Check Avanos Medical Probability Of Bankruptcy
Ownership Allocation
Avanos Medical holds a total of 45.96 Million outstanding shares. The majority of Avanos Medical outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Avanos Medical to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Avanos Medical. Please pay attention to any change in the institutional holdings of Avanos Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Avanos Ownership Details

Avanos Stock Institutional Holders

InstituionRecorded OnShares
Neuberger Berman Group Llc2024-06-30
998 K
Tributary Capital Management, Llc2024-06-30
743.1 K
Morgan Stanley - Brokerage Accounts2024-06-30
718.2 K
Royal Bank Of Canada2024-06-30
587.9 K
Prudential Financial Inc2024-09-30
586.7 K
Charles Schwab Investment Management Inc2024-09-30
523.5 K
Northern Trust Corp2024-09-30
502 K
Bank Of New York Mellon Corp2024-06-30
382.2 K
D. E. Shaw & Co Lp2024-09-30
345.7 K
Blackrock Inc2024-06-30
M
Vanguard Group Inc2024-09-30
5.3 M
View Avanos Medical Diagnostics

Avanos Medical Historical Income Statement

At this time, Avanos Medical's Non Operating Income Net Other is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 286.2 M in 2024. View More Fundamentals

Avanos Stock Against Markets

Avanos Medical Corporate Directors

Patrick OLearyIndependent DirectorProfile
Julie ShimerIndependent DirectorProfile
William HawkinsIndependent DirectorProfile
Heidi KunzIndependent DirectorProfile

Already Invested in Avanos Medical?

The danger of trading Avanos Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Avanos Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Avanos Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Avanos Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.